| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |